Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
panTB-HM
PACTR202301805346465Phase 2Unknown
- Sponsor
- Aurum Institute
- Start
- Jan 2023
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Phase 2 trial of sutezolid, bedaquiline, pretomanid, acetylcysteine, isoniazid and 3 more, sponsored by Aurum Institute. Status: unknown.
02
Drugs
sutezolidbedaquilinepretomanidacetylcysteineisoniazid
Beyond the preview
Go deeper on PACTR202301805346465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202301805346465.